Lorenzo1234567
Posted - 9 minutes from now
$CRDL
Lorenzo1234567
Posted - 2 minutes from now
$CRDL You can guarantee FDA approval here. As i stated before RFK takes over/rebrands the FDA soon. He has always been skeptical of many vaccines and there potential side effects, specifically the Covid vaccine. Turns out he was right..Hmm A new landmark drug thats treats this, derived from CBD. RFK has preached CBD/Marijuana for medicinal value. Perfect storm. Can you say fast track approval?? Can you say revenge??
Theo77
Posted - 3 minutes ago
$CRDL
Theo77
Posted - 29 minutes ago
$CRDL
Theo77
Posted - 1 hour ago
$CRDL
ElieoG
Posted - 2 hours ago
$CRDL so 2 more years of waiing or a little less hophelly .If badluck strikes and they are not approved can they contest the decision and ask for a second verdict?
StreetwiseReports
Posted - 6 hours ago
Analyst Says Biotech's Data Supports Advancement Into Phase III: https://ow.ly/LtU550UavAw Cardiol Therapeutics recently released updated Phase II data from the MAvERIC trial testing CardiolRx in recurrent pericarditis, according to a Leede Financial Inc. research note. $CRDL #biotechstocks
Covode13
Posted - 6 hours ago
$CRDL if we end up gettting approval on one drug at least. What’s the estimated price will we end up at. Like $DRUG they jumped to 55 share price before falling back down to 30’s right now I believe it’s at.
Covode13
Posted - 6 hours ago
$CRDL if we do go back below 1. I’ll be buying thousands of shares to lower my share price. So the next small move I’ll sell and rebuy. Only way to make profit on this long long intern hold for this to be approved
Covode13
Posted - 6 hours ago
$CRDL
TradeEd24
Posted - 8 hours ago
$CRDL What exactly is it going to take to move this ticker? Good news after good news and it is still red.
Skichic
Posted - 8 hours ago
$CRDL The market for the drug is huge!
Skichic
Posted - 8 hours ago
$CRDL Just bought a nice starter here. I have suffered from Pericarditis and sure the heck wish I’d had access to a drug like this. It’s an incredibly painful condition and all they have to treat it with is high dose NSAIDS every 4 hours, which eat your stomach up. Mine lasted 9 months and it can recur. It feels like you’re having a never ending heart attack.
Blberry23
Posted - 9 hours ago
$CRDL COME RIP $TRIB BOTTOMED OUT BIOTECH
Covode13
Posted - 9 hours ago
$CRDL
StockQuen
Posted - 9 hours ago
NASDAQ: $CRDL Add now, Big opportunity 12-Month Price Target: $10 based on a sum-of-the-parts valuation. This approach aligns with industry standards, utilizing a 3x sales multiple and a 9% WACC.
HotStockNews
Posted - 9 hours ago
NASDAQ: $CRDL add More in this DIP, News Coming INSIDER BUYING : Cardiol CEO David Elsley purchased approximately $100,000 in shares at about $2.03 each, indicating strong personal conviction in the company's potential.
SeanWav
Posted - 10 hours ago
$NVDA $CRDL The data reported today show that patients enrolled in MAvERIC-Pilot, despite the severity of their disease, experienced clinically relevant and rapid reductions in both their pericarditis pain and C-reactive protein levels that were maintained throughout the study. In addition, results demonstrated a substantial reduction in pericarditis episodes per year as compared to the patients' historical event rate prior to the study. Importantly, treatment was shown to be safe and well tolerated in a population who presented with significant disease burden
SeanWav
Posted - 10 hours ago
$CRDL “Importantly, treatment was shown to be safe and well tolerated in a population who presented with significant disease burden” More than BULLISH. to $20+++++ soon
SeanWav
Posted - 10 hours ago
$CRDL The data reported today show that patients enrolled in MAvERIC-Pilot, despite the severity of their disease, experienced clinically relevant and rapid reductions in both their pericarditis pain and C-reactive protein levels. Importantly, treatment was shown to be safe and well tolerated in a population who presented with significant disease burden.
SeanWav
Posted - 10 hours ago
$CRDL The data reported today show that patients enrolled in MAvERIC-Pilot, despite the severity of their disease, experienced clinically relevant and rapid reductions in both their pericarditis pain and C-reactive protein levels that were maintained throughout the study. In addition, results demonstrated a substantial reduction in pericarditis episodes per year as compared to the patients' historical event rate prior to the study. Importantly, treatment was shown to be safe and well tolerated in a population who presented with significant disease burden.
SeanWav
Posted - 10 hours ago
$CRDL great results submitted to American Heart Association. This is the final opportunity to grab some cheap shares . This should be $20++++ soon
SeanWav
Posted - 10 hours ago
$CRDL to $20+++ coming 🚀🚀🚀🚀💰💰💰💰
SeanWav
Posted - 10 hours ago
$CRDL 🚀🚀🚀💰💰💰💰💰
Covode13
Posted - 11 hours ago
$CRDL
Theo77
Posted - 11 hours ago
$CRDL
StockQuen
Posted - 11 hours ago
NASDAQ: $CRDL Breaking News: Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024
Theo77
Posted - 11 hours ago
$CRDL
BabyfaceMcD
Posted - 12 hours ago
$CRDL nice moves $AZI hitting scanners easy over 3 today
PDM21
Posted - 12 hours ago
$CRDL at what point to companies start make offers before the competition does? At what point does kiniska start to get concerned enough to be that company